Philmans Pharm,, The German Patient Roundtable

Est. 1977

Germany – 1 March 2017 update – Cannabis legislation has not yet been published in the Federal Gazette

Even if the Bundestag and the Federal Council have decided to make it easier for patients who are seriously ill in future to gain access to medicine from cannabis blossoms and extracts , the cannabis legislation has not yet been published in the Federal Gazette. Thus, contrary to the reports of different news portals, probably no marijuana from today will give on prescription in pharmacies for patients without exception permission.


The last February day offered some new laws and legal changes in the Federal Law Gazette , but no publication of the cannabis as a medical law can be found in the table of contents of the first part of the publication of 28.02.2017, which provides information on the federal laws now in force. As a result, the right to prescribe the cost of cannabis medicines by health insurance companies from March 1 is as little the same as the state license, which may be allowed to be licensed to the medical profession, which may have recently been prescribed by a doctor. On the other hand, however, first steps can be found in publications of 17.02.2017,


The fact that a publication in the Federal Chancellor is always imperative before the coming into effect of a law , but nevertheless urbayrian media gave their local audience conscientiously before the first day of the month of March, before these also have to get used to the changed circumstances in dealing with the demonized drug .


As soon as it is in the Federal Court, the law applies to all.


Over the last 4 decades I have been involved in the fight for patient rights in America, and now here in Germany. During my career I have served as a Board of Director for the World Trade Center San Diego and as a Lead Consultant for Deutsche Telekom's Executive Board, Co-Founded the San Diego Software Council and the Dayton Human Trafficking Accords and was Director of LawInfo's Lead Council Program. Previously I was a C-Level Business Development Executive in the technology sector, but also involved with the cannabis industry since 1977. More recently I have been fulltime in the legal medical marijuana industry here in Europe, helping international companies navigate the biggest potential market in the world. This website is light on details due to confidentiality issues with clients but be rest assured I am knowledgeable, professional and with street cred in the industry that can immediately assist your growth in some way. Consulting Services: Sales and Business Development Assist with Strategic Direction Professionally represent your firm Special Projects management Licensing and compliance Sales and Distribution networks Qualify potential partners I am your resource on the ground in Europe, contact me directly to schedule an initial discussion on the German Cannabis-as-Medicine market. Thank you, Philip J. Cenedella IV Call +1.888.206.3264 USA + GERMANY Skype: philip.j.cenedella eMail: LinkedIN:

Comments are closed.